{"id":16620,"date":"2026-06-10T17:17:39","date_gmt":"2026-06-10T15:17:39","guid":{"rendered":"https:\/\/www.interpharma.ch\/?p=16620"},"modified":"2026-06-10T17:17:41","modified_gmt":"2026-06-10T15:17:41","slug":"3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/","title":{"rendered":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"2560\" src=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-scaled.jpg\" alt=\"\" class=\"wp-image-16624\" srcset=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-scaled.jpg 2560w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-800x800.jpg 800w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-1200x1200.jpg 1200w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-300x300.jpg 300w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-768x768.jpg 768w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-1536x1536.jpg 1536w, https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-2048x2048.jpg 2048w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-en-suisse-les-patientes-et-patients-attendent-souvent-plus-longtemps-les-nouveaux-traitements-que-dans-les-pays-voisins-que-faut-il-faire-changer\"><strong><strong><strong><strong>En Suisse, les patientes et patients attendent souvent plus longtemps les nouveaux traitements que dans les pays voisins. Que faut-il faire changer?<\/strong><\/strong><\/strong><\/strong><\/h2>\n\n\n\n<p>La Suisse est un pays hautement innovant, au pouvoir d\u2019achat \u00e9lev\u00e9, et qui a une longue tradition de succ\u00e8s de l\u2019industrie pharmaceutique. Mais elle a omis de pr\u00e9parer son syst\u00e8me de sant\u00e9 \u00e0 toute une s\u00e9rie de traitements pionniers qui sont disponibles depuis quelques ann\u00e9es ou le seront bient\u00f4t.<\/p>\n\n\n\n<p>Les donn\u00e9es sont claires sur le fait que l\u2019acc\u00e8s aux m\u00e9dicaments innovants ralentit. Alors qu\u2019\u00e0 l\u2019\u00e9chelon international, la formation des prix est en pleine mutation, les propositions actuelles de r\u00e9vision de l\u2019OAMal menacent de d\u00e9grader encore plus l\u2019acc\u00e8s \u00e0 l\u2019innovation en Suisse.<\/p>\n\n\n\n<p>La Suisse est \u00e0 la crois\u00e9e des chemins. Mon \u00e9quipe et moi-m\u00eame travaillons avec Interpharma au d\u00e9veloppement de solutions convaincantes qui r\u00e9compensent l\u2019innovation, acc\u00e9l\u00e8rent l\u2019acc\u00e8s des patientes et patients et permettent un avenir en meilleure sant\u00e9 bas\u00e9 sur nos travaux de recherche.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-que-faut-il-faire-pour-que-la-place-pharmaceutique-suisse-reste-a-la-pointe-de-l-europe-a-l-avenir\"><strong><strong><strong><strong>Que faut-il faire pour que la place pharmaceutique suisse reste \u00e0 la pointe de l\u2019Europe \u00e0 l\u2019avenir?<\/strong><\/strong><\/strong><\/strong><\/h2>\n\n\n\n<p>L\u2019attrait de la Suisse en tant que place pharmaceutique d\u00e9pend \u00e0 la fois des conditions cadres politiques et de l\u2019excellence scientifique.<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Le principal d\u00e9fi est le nouveau r\u00f4le de la Suisse en tant que pays de r\u00e9f\u00e9rence pour les \u00c9tats-Unis. On observe d\u00e8s \u00e0 pr\u00e9sent un effet dissuasif sur les d\u00e9cisions de mise sur le march\u00e9. Si les entreprises commencent \u00e0 moins prioriser la Suisse pour les mises sur le march\u00e9 pr\u00e9coces, cela multipliera les cons\u00e9quences pour la r\u00e9putation et l\u2019\u00e9conomie, avec un impact non seulement sur la branche, mais aussi sur les revenus fiscaux, les investissements dans la recherche et les emplois dans les cantons.<\/li>\n\n\n\n<li>\u00a0Le mod\u00e8le de primes par t\u00eate est une entrave structurelle \u00e0 la disposition de la Suisse \u00e0 investir dans les m\u00e9dicaments innovants. Il faut donc s\u00e9rieusement envisager de nouveaux m\u00e9canismes de financement, entre autres un financement par les imp\u00f4ts et des projets pilotes cantonaux.<\/li>\n\n\n\n<li>La Suisse a fait un grand pas en avant en mettant en place un groupe de travail national pour une strat\u00e9gie des sciences de la vie. Mais ce n\u2019est qu\u2019un d\u00e9but: la vraie question sera de savoir si les cercles politiques suisses mettent en \u0153uvre les recommandations du groupe de travail sous forme de mesures politiques concr\u00e8tes ou si ces recommandations restent lettre morte.<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-a-cet-egard-que-pouvez-vous-apporter-au-comite-directeur-d-interpharma-grace-a-vos-experiences-dans-differents-pays-fonctions-et-domaines-therapeutiques\"><strong><strong><strong><strong>\u00c0 cet \u00e9gard, que pouvez-vous apporter au comit\u00e9 directeur d\u2019Interpharma gr\u00e2ce \u00e0 vos exp\u00e9riences dans diff\u00e9rents pays, fonctions et domaines th\u00e9rapeutiques?<\/strong><\/strong><\/strong><\/strong><\/h2>\n\n\n\n<p>Au cours de mes 14&nbsp;ann\u00e9es chez Lilly, je suis pass\u00e9e de la strat\u00e9gie de prix et de remboursement aux \u00c9tats-Unis, y compris la responsabilit\u00e9 des premiers accords de financement bas\u00e9 sur les r\u00e9sultats, \u00e0 la direction d\u2019une filiale commerciale \u00e0 Gen\u00e8ve \u00e0 une \u00e9poque de croissance importante et de complexit\u00e9 g\u00e9opolitique, en passant par le d\u00e9veloppement des affaires de l\u2019ensemble du groupe dans les domaines oncologie, neurosciences, immunologie et m\u00e9decine g\u00e9n\u00e9tique.<\/p>\n\n\n\n<p>Gr\u00e2ce \u00e0 ce large \u00e9ventail, je ne vois pas les d\u00e9fis de l\u2019acc\u00e8s au march\u00e9 en Suisse uniquement comme un probl\u00e8me local de la filiale, mais dans le contexte de l\u2019ensemble de la cha\u00eene de valeur ajout\u00e9e: de la d\u00e9couverte et du financement des innovations \u00e0 la formation des prix, au remboursement et finalement \u00e0 la prise en charge des patientes et patients.<\/p>\n\n\n\n<p>Ayant d\u00e9j\u00e0 travaill\u00e9 aux \u00c9tats-Unis et au Canada, et \u00e0 pr\u00e9sent en Suisse, j\u2019ai un horizon d\u2019exp\u00e9riences internationales. \u00c0 mon avis, ceci est directement pertinent pour les questions \u00e0 l\u2019ordre du jour d\u2019Interpharma, en particulier celles li\u00e9es \u00e0 la formation des prix dans le cadre de la nation la plus favoris\u00e9e, \u00e0 la r\u00e9forme du prix de r\u00e9f\u00e9rence international (IRP) et aux conditions pour que la Suisse reste un pays privil\u00e9gi\u00e9 pour les mises sur le march\u00e9.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lauren McNamer, General Manager de Lilly Switzerland<\/p>\n","protected":false},"author":12,"featured_media":16624,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[59,120,130,149,182],"class_list":["post-16620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-forschung","tag-innovation-fr","tag-pharmastandort-2030-fr","tag-recherche-et-developpement"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland - Interpharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland\" \/>\n<meta property=\"og:description\" content=\"Lauren McNamer, General Manager de Lilly Switzerland\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-10T15:17:39+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-10T15:17:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"2560\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"livantonsen\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"livantonsen\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/\"},\"author\":{\"name\":\"livantonsen\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/7d959c3353600fdf7ed5dde22078d158\"},\"headline\":\"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland\",\"datePublished\":\"2026-06-10T15:17:39+00:00\",\"dateModified\":\"2026-06-10T15:17:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/\"},\"wordCount\":705,\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Lauren-McNamer_3MB-file-size-scaled.jpg\",\"keywords\":[\"Forschung\",\"Innovation\",\"Pharmastandort 2030\",\"recherche et d\u00e9veloppement\",\"Forschung\"],\"inLanguage\":\"fr-FR\",\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/\",\"name\":\"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland - Interpharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Lauren-McNamer_3MB-file-size-scaled.jpg\",\"datePublished\":\"2026-06-10T15:17:39+00:00\",\"dateModified\":\"2026-06-10T15:17:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Lauren-McNamer_3MB-file-size-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Lauren-McNamer_3MB-file-size-scaled.jpg\",\"width\":2560,\"height\":2560},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/blog\\\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/7d959c3353600fdf7ed5dde22078d158\",\"name\":\"livantonsen\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g\",\"caption\":\"livantonsen\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland - Interpharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/","og_locale":"fr_FR","og_type":"article","og_title":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland","og_description":"Lauren McNamer, General Manager de Lilly Switzerland","og_url":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/","og_site_name":"Interpharma","article_published_time":"2026-06-10T15:17:39+00:00","article_modified_time":"2026-06-10T15:17:41+00:00","og_image":[{"width":2560,"height":2560,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-scaled.jpg","type":"image\/jpeg"}],"author":"livantonsen","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"\u00c9crit par":"livantonsen","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/"},"author":{"name":"livantonsen","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/7d959c3353600fdf7ed5dde22078d158"},"headline":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland","datePublished":"2026-06-10T15:17:39+00:00","dateModified":"2026-06-10T15:17:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/"},"wordCount":705,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-scaled.jpg","keywords":["Forschung","Innovation","Pharmastandort 2030","recherche et d\u00e9veloppement","Forschung"],"inLanguage":"fr-FR","copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/","url":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/","name":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland - Interpharma","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-scaled.jpg","datePublished":"2026-06-10T15:17:39+00:00","dateModified":"2026-06-10T15:17:41+00:00","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-scaled.jpg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/06\/Lauren-McNamer_3MB-file-size-scaled.jpg","width":2560,"height":2560},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/fr\/blog\/3-questions-a-notre-nouveau-membre-du-conseil-dadministration-lauren-mcnamer-general-manager-de-lilly-switzerland\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"3 questions \u00e0 notre nouveau membre du conseil d\u2019administration: Lauren McNamer, General Manager de Lilly Switzerland"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/7d959c3353600fdf7ed5dde22078d158","name":"livantonsen","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/381670883a2bb428497a0e409bd947df62cefce2a71135b42fb98e92196bfabc?s=96&d=mm&r=g","caption":"livantonsen"}}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=16620"}],"version-history":[{"count":2,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16620\/revisions"}],"predecessor-version":[{"id":16631,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/16620\/revisions\/16631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media\/16624"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=16620"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=16620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}